Immune Sciences News Today

Frazier Life Sciences Management L.P. lifted its holdings in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) by 4.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,131,008 shares of the biotechnology company’s stock after buying an additional 145,251 shares during the quarter. Alpine […]

Capstone Investment Advisors LLC purchased a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 25,289 shares of the biotechnology company’s stock, valued at approximately $482,000. Other institutional investors also […]

Monashee Investment Management LLC purchased a new position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 74,792 shares of the biotechnology company’s stock, valued at approximately $1,426,000. A number of other institutional investors […]

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, ...

NEW YORK, April 20, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or

The biotech just added another potential growth driver to its pipeline.

Jumps for Big Tech stocks helped U.S. stock indexes claw back much of their slide from the day before, when worries that interest rates may stay high for a while

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

NEW YORK -- Jumps for Big Tech on Thursday helped U.S. stock indexes claw back much of their slide from the day before.